“…The diabetic state is defined by clinical examinations, with findings such as polyuria, polydipsia, polyphagia and rapid, spontaneous weight loss, and by laboratory exams, such as fasting glucose, oral glucose tolerance test (OGTT with a 75-gram dextrose challenge) and random glucose. ( 18 ) It is also interesting to assess DM progression based on the inflammatory process, comparing with body fat distribution, obesity and its risk factors, such as, for instance, cholesterol, as well as glucotoxicity, such as serum insulin and cytokine levels, CRP levels, interleukins and immunoinflammatory markers, in addition to lipid profile, adiponectin levels, and adipose tissue immunohistochemistry, by using methods like Western blot and enzyme-linked immunosorbent assay (ELISA). ( 19 ) This shows the relevance of our findings, the importance of new research studies on complications resulting from inflammation-related metabolic dysfunctions and, consequently, the need for greater efficacy and more options to manage DM.…”